• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA365¿ INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA365¿ INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50012
Device Problem Expulsion (2933)
Patient Problems Hemorrhage/Bleeding (1888); Gastrointestinal Hemorrhage (4476)
Event Date 06/17/2022
Event Type  malfunction  
Event Description
During implant of balloon it was noticed that there were two tears in the oesophagus.The tears were repaired with 4 clips and the balloon was removed never inflated in patient.Patient is doing fine and was released the same day.
 
Manufacturer Narrative
A review of the device labeling notes the following: the current orbera365¿ intragastric balloon system directions for use (dfu) addresses the known and anticipated potential events of "deflation, vomiting and early removal "as follows: "the physiological response of the patient to the presence of the orbera365¿system balloon may vary depending upon the patient's general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response." "each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms." "complications: possible complications of the use of the orbera365¿ system include: -gastric discomfort, feelings of nausea and vomiting following balloon placement as the digestive system adjusts to the presence of the balloon.-patients reporting loss of satiety, increased hunger and/or weight gain should be examined endoscopically as this is indicative of an igb deflation.-a patient who's deflated (i.E.Collapsed) igb has moved into the intestines must be monitored closely for an appropriate period of time (at least 2 weeks) to confirm its uneventful passage through the intestine.- abdominal or back pain, either steady or cyclic.- deflation and subsequent replacement." - deflated device should be removed promptly.Possible adverse events · intestinal obstruction by the igb.An insufficiently filled igb or a leaking igb that has lost sufficient volume may be able to pass from the stomach into the small bowel.It may pass all the way into the colon and be passed with stool.However, if there is a narrow area in the bowel or adhesion formation, which may occur after previous surgery on the bowel, the igb may not pass and could cause a bowel obstruction.If this occurs, surgery or endoscopic removal could be required.· insufficient or no weight loss.· igb deflation (i.E.Collapse) and subsequent replacement.Additional information: the device has not been returned for analysis.A device history record (dhr) review is pending for reporting purposes.There were no other complaints in the apollo database against this lot number , af04951.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA365¿ INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON SYSTEM
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s. capital of texas hwy
bldg 1, ste. 300
austin TX 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA, SRL
coyol free zone
building b 13.3
alajuela, cs CRI
CS   CRI
Manufacturer Contact
david hooper
1120 s. captail of texas hwy
bldg 1, ste 300
austin, TX 78746
5128523757
MDR Report Key15103207
MDR Text Key304275686
Report Number3006722112-2022-00074
Device Sequence Number1
Product Code LTI
UDI-Device Identifier10811955020725
UDI-Public(01)10811955020725(17)20240316(10)AF04951
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/16/2024
Device Model NumberB-50012
Device Catalogue NumberB-50012
Device Lot NumberAF04951
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/28/2022
Initial Date FDA Received07/26/2022
Date Device Manufactured03/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age33 YR
Patient SexMale
Patient Weight136 KG
-
-